APA

Clarke N. W., Ali A., Ingleby F. C., Hoyle A., Amos C. L., Attard G., Brawley C. D., Calvert J., Chowdhury S., Cook A., Cross W., Dearnaley D. P., Douis H., Gilbert D., Gillessen S., Jones R. J., Langley R. E., MacNair A., Malik Z., Mason M. D., Matheson D., Millman R., Parker C. C., Ritchie A. W. S., Rush H., Russell J. M., Brown J., Beesley S., Birtle A., Capaldi L., Gale J., Gibbs S., Lydon A., Nikapota A., Omlin A., O'Sullivan J. M., Parikh O., Protheroe A., Rudman S., Srihari N. N., Simms M., Tanguay J. S., Tolan S., Wagstaff J., Wallace J., Wylie J., Zarkar A., Sydes M. R., Parmar M. K. B. & James N. D. (2020). Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Clarke N W, Ali A, Ingleby F C, Hoyle A, Amos C L, Attard G, Brawley C D, Calvert J, Chowdhury S, Cook A, Cross W, Dearnaley D P, Douis H, Gilbert D, Gillessen S, Jones R J, Langley R E, MacNair A, Malik Z, Mason M D, Matheson D, Millman R, Parker C C, Ritchie A W S, Rush H, Russell J M, Brown J, Beesley S, Birtle A, Capaldi L, Gale J, Gibbs S, Lydon A, Nikapota A, Omlin A, O'Sullivan J M, Parikh O, Protheroe A, Rudman S, Srihari N N, Simms M, Tanguay J S, Tolan S, Wagstaff J, Wallace J, Wylie J, Zarkar A, Sydes M R, Parmar M K B and James N D. 2020. Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Clarke N. W., Ali A., Ingleby F. C., Hoyle A., Amos C. L., Attard G., Brawley C. D., Calvert J., Chowdhury S., Cook A., Cross W., Dearnaley D. P., Douis H., Gilbert D., Gillessen S., Jones R. J., Langley R. E., MacNair A., Malik Z., Mason M. D., Matheson D., Millman R., Parker C. C., Ritchie A. W. S., Rush H., Russell J. M., Brown J., Beesley S., Birtle A., Capaldi L., Gale J., Gibbs S., Lydon A., Nikapota A., Omlin A., O'Sullivan J. M., Parikh O., Protheroe A., Rudman S., Srihari N. N., Simms M., Tanguay J. S., Tolan S., Wagstaff J., Wallace J., Wylie J., Zarkar A., Sydes M. R., Parmar M. K. B. and James N. D. (2020). Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Clarke N W, Ali A, Ingleby F C, Hoyle A, Amos C L, Attard G, Brawley C D, Calvert J, Chowdhury S, Cook A, Cross W, Dearnaley D P, Douis H, Gilbert D, Gillessen S, Jones R J, Langley R E, MacNair A, Malik Z, Mason M D, Matheson D, Millman R, Parker C C, Ritchie A W S, Rush H, Russell J M, Brown J, Beesley S, Birtle A, Capaldi L, Gale J, Gibbs S, Lydon A, Nikapota A, Omlin A, O'Sullivan J M, Parikh O, Protheroe A, Rudman S, Srihari N N, Simms M, Tanguay J S, Tolan S, Wagstaff J, Wallace J, Wylie J, Zarkar A, Sydes M R, Parmar M K B and James N D. Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003. : Annals of oncology : official journal of the European Society for Medical Oncology. 2020.